Envarsus XR 4 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,301
Award facts
- Contract value 100% obligated
- $22,301.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22.3K to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of February 17, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, specialty drugs, vaccines, and related medical supplies to military healthcare systems worldwide.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders across multiple therapeutic domains, including specialty medications for conditions such as organ transplant rejection management and diabetes care. This delivery order for Envarsus XR, an immunosuppressant medication used in transplant patients, exemplifies the company's role in supplying essential pharmaceutical commodities to support military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQV2Z?
SPE2DR26FQV2Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FQV2Z worth?
The government has obligated $22,301 on SPE2DR26FQV2Z.
Is contract SPE2DR26FQV2Z an order under another contract?
Yes. SPE2DR26FQV2Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2Z competed?
The extent of competition for SPE2DR26FQV2Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award